GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » FS KKR Capital Corp (NYSE:FSK) » Definitions » Change In Payables And Accrued Expense

FSK (FS KKR Capital) Change In Payables And Accrued Expense : $0.0 Mil (TTM As of Sep. 2024)


View and export this data going back to 2014. Start your Free Trial

What is FS KKR Capital Change In Payables And Accrued Expense?

FS KKR Capital's Change In Payables And Accrued Expense for the quarter that ended in Sep. 2024 was $0.0 Mil. It means FS KKR Capital's Accounts Payable & Accrued Expense stayed the same from Jun. 2024 to Sep. 2024 .

FS KKR Capital's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2023 was $0.0 Mil. It means FS KKR Capital's Accounts Payable & Accrued Expense stayed the same from Dec. 2022 to Dec. 2023 .


FS KKR Capital Change In Payables And Accrued Expense Historical Data

The historical data trend for FS KKR Capital's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

FS KKR Capital Change In Payables And Accrued Expense Chart

FS KKR Capital Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Change In Payables And Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

FS KKR Capital Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Change In Payables And Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

FS KKR Capital Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


FS KKR Capital Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of FS KKR Capital's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


FS KKR Capital Business Description

Industry
Traded in Other Exchanges
Address
201 Rouse Boulevard, Philadelphia, PA, USA, 19112
FS KKR Capital Corp is a business development company based in the United States. Its portfolio is comprised of investments in senior secured loans and second lien secured loans of private middle market U.S. companies and, to a lesser extent, subordinated loans and certain asset-based financing loans of private U.S. companies. It is focused on providing customized credit solutions to private upper middle-market companies, which it generally defines as companies with annual EBITDA of at least $50 million at the time of investment.
Executives
Elizabeth Sandler director 201 ROUSE BLVD, PHILADELPHIA PA 19112
Brian Gerson officer: President, other: Investment Committee Member C/O SOLAR CAPITAL LTD., 500 PARK AVENUE, NEW YORK NY 10022
Osagie O Imasogie director
Michael C. Forman director, officer: President and CEO CIRA CENTRE, 2929 ARCH STREET, SUITE 675, PHILADELPHIA PA 19104-2867
Daniel Pietrzak officer: Chief Investment Officer 9 WEST 57TH STREET, SUITE 4200, NEW YORK NY 10019
Jerel A Hopkins director C/O FS INVESTMENT CORPORATION II, CIRA CENTRE, 2929 ARCH STREET, SUITE 675, PHILADELPHIA PA 19104
Barbara Adams director 112 NORTH WOOSTOCK STREET, PHILADELPHIA PA 19103
Richard I Goldstein director C/O INTELLON CORPORATION, 5955 T.G. LEE BLVD., SUITE 600, ORLANDO FL 32822
James H Kropp director 701 WESTERN AVENUE, GLENDALE CA 91201
Brian R. Ford director 1 MILFORD WAY, MEDFORD NJ 08055
Todd C. Builione director, officer: President C/O KKR CREDIT ADVISORS (US) LLC, 9 WEST 57TH STREET, NEW YORK NY 10019
William Balke Goebel officer: Chief Financial Officer C/O FS INVESTMENT CORP., CIRA CENTRE, 2929 ARCH STREET, SUITE 675, PHILADELPHIA PA 19104-2867
Stephen Sypherd officer: VP, Treasurer & Secretary C/O FRANKLIN SQUARE CAPITAL PARTNERS, CIRA CENTRE, 2929 ARCH STREET, SUITE 675, PHILADELPHIA PA 19104
Steven C Lilly officer: Chief Financial Officer 1004 FARNAM STREET, SUITE 400, OMAHA NE 27511
Michael J Hagan director 555 EAST LANCASTER AVENUE, SUITE 640, RADNOR PA 19087